120 related articles for article (PubMed ID: 11229253)
1. L-carnitine administration in coronary artery disease and cardiomyopathy.
Singh RB; Aslam M
J Assoc Physicians India; 1998 Sep; 46(9):801-5. PubMed ID: 11229253
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
3. [Physiologic bases for the use of L-carnitine in cardiology].
Krähenbühl S
Praxis (Bern 1994); 1998 Jan; 87(4):102-7. PubMed ID: 9522639
[TBL] [Abstract][Full Text] [Related]
4. [Carnitine metabolism--changes in the end stage of dilated cardiomyopathy and ischemic heart muscle disease].
Regitz V; Müller M; Schüler S; Yankah CA; Hetzer R; Shug AL; Fleck E
Z Kardiol; 1987; 76 Suppl 5():1-8. PubMed ID: 3324528
[TBL] [Abstract][Full Text] [Related]
5. Intravenous dl-carnitine fails to increase the double-product during atrial pacing in patients with effort angina. A double-blind randomized study.
Biagini A; Opie L; Rovai D; Mazzei MG; Carpeggiani C; Maseri A
G Ital Cardiol; 1983 Nov; 13(11):291-4. PubMed ID: 6667814
[TBL] [Abstract][Full Text] [Related]
6. New thoughts of pathophysiology and therapy of ischemic heart disease.
Pepine CJ
Cardiologia; 1991 Dec; 36(12 Suppl 1):373-7. PubMed ID: 1841793
[TBL] [Abstract][Full Text] [Related]
7. [The effect of L-carnitine on ischemic heart disease: experimental results].
Lerch R
Praxis (Bern 1994); 1998 Jan; 87(4):97-100. PubMed ID: 9522638
[TBL] [Abstract][Full Text] [Related]
8. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.
Helton E; Darragh R; Francis P; Fricker FJ; Jue K; Koch G; Mair D; Pierpont ME; Prochazka JV; Linn LS; Winter SC
Pediatrics; 2000 Jun; 105(6):1260-70. PubMed ID: 10835067
[TBL] [Abstract][Full Text] [Related]
9. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
10. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
11. Carnitine and its role in cardiovascular disease.
Retter AS
Heart Dis; 1999; 1(2):108-13. PubMed ID: 11720611
[TBL] [Abstract][Full Text] [Related]
12. L-carnitine.
Med Lett Drugs Ther; 2004 Nov; 46(1196):95-6. PubMed ID: 15557875
[TBL] [Abstract][Full Text] [Related]
13. Metabolic agents in the management of diabetic coronary patients: a new era.
Celik T; Kursaklioglu H; Iyisoy A; Jata B
Int J Cardiol; 2008 Jun; 127(1):133-4. PubMed ID: 17561287
[TBL] [Abstract][Full Text] [Related]
14. L-Carnitine: therapeutic applications of a conditionally-essential amino acid.
Kelly GS
Altern Med Rev; 1998 Oct; 3(5):345-60. PubMed ID: 9804680
[TBL] [Abstract][Full Text] [Related]
15. [L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review].
Fernandez C; Proto C
Clin Ter; 1992 Apr; 140(4):353-77. PubMed ID: 1534043
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of carnitine in cardiovascular disorders.
Pepine CJ
Clin Ther; 1991; 13(1):2-21; discussion 1. PubMed ID: 2029724
[TBL] [Abstract][Full Text] [Related]
17. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
[TBL] [Abstract][Full Text] [Related]
18. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial protective effect of L-carnitine in cardioplegia solution on patients undergoing heart valve replacement operation].
Xiang DK; Yan XZ; Yang SY; Liu XL; Hu XY; Zhou T
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1887-90. PubMed ID: 14642073
[TBL] [Abstract][Full Text] [Related]
20. Anti-anginal effects of partial fatty acid oxidation inhibitors.
Lam A; Lopaschuk GD
Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
